The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.103
Bid: 0.0982
Ask: 0.103
Change: 0.004 (4.04%)
Spread: 0.0048 (4.888%)
Open: 0.103
High: 0.103
Low: 0.103
Prev. Close: 0.099
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

South American Graphinks Agreements

14 Mar 2024 07:00

RNS Number : 7801G
Versarien PLC
14 March 2024
 

14 March 2024

Versarien Plc

("Versarien", the "Company" or the "Group")

South American Graphinks? Agreements

Versarien Plc (AIM: VRS), the advanced materials engineering group, announces that the Company has, in line with its stated strategy to monetise intellectual property through licensing, entered into a manufacturing licence agreement and a know-how licence and technical assistance agreement (together the "Agreements") with Montana Química LTDA ("Montana"). Montana is a Brazilian headquartered multinational business focused on the production and sale of paints, wood preservatives and other wood finishing products including stains and varnishes.  The Agreements cover the use of certain of the Company's proprietary graphene and related material dispersions and formulations (Graphinks?) in products to be manufactured and sold by Montana in South America, together with Versarien providing further additional know-how, technical assistance and training to Montana.

Further Details on the Agreements

Under the terms of the Agreements, Versarien has granted a licence to Montana (the "Licence"), for an initial period of five years, to use certain intellectual property and know-how owned by the Company in their business in South America. Montana will pay Versarien initial fees of £50,000 in March 2024 in consideration of the know-how and technical assistance, including training, to be provided. Once Montana commences manufacturing under the Agreement, a further payment of £25,000 will be due to the Company, together with an amount equal to 5% of the total sales revenue earned from products manufactured using Versarien's intellectual property and know-how ("Royalty"), subject to minimum Royalty payments of £25,000 per annum.

Dr Stephen Hodge, CEO of Versarien, commented: "The Agreements with Montana are in line with Versarien's strategy to be a manufacturing-light business in the UK and licence our patents, know-how and other intellectual property to key partners. We are very pleased to be partnering with Montana, a leading business in its markets in South America, and look forward to collaborating closely with them as they bring products enhanced by Versarien's technology to the market."

Andreas von Salis, CEO of Montana, commented: "The Agreements with Versarien give Montana the opportunity to capitalise on the growing markets for graphene in Brazil with the intention to utilise graphene in application areas such as paints, coatings and lubricants."

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

 

+44 (0)20 3470 0470

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien Graphinks?

 

Versarien's Graphinks? are graphene and related material (GRM) inks and dispersions that bring multi-functionality (high electrical and thermal conductivity, fire retardation, UV protection, etc.), produced via a high pressure homogenisation process that offers high yield and uniform size distribution. Versarien have 'standard' Graphinks? for different deposition methods from inkjet to screen printing and developmental formulations with different nanomaterials and solvent combinations.

 

For further information please see: http://www.versarien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRGPUWUWUPCPGW
Date   Source Headline
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:35 pmRNSPrice Monitoring Extension
16th Oct 20205:18 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSAdvisory Panel
24th Sep 202012:07 pmRNSResult of AGM
23rd Sep 20207:00 amRNSPosting of Annual Report
1st Sep 20207:00 amRNSNotice of AGM
17th Aug 20207:00 amRNSUpdate re. Innovate UK Loan Agreement
11th Aug 20207:00 amRNSPreliminary Results
3rd Aug 20207:00 amRNSLaunch of Graphene Enhanced Protective Face Mask
1st Jul 20207:01 amRNS£5 million Innovate UK Loan Agreement
1st Jul 20207:00 amRNSCorporate Update and Notice of Results
19th Jun 20207:00 amRNSAppointment of Non-executive Chairman
12th Jun 20209:41 amRNSInvestor Communication
4th Jun 202012:02 pmRNSPrice Monitoring Extension
19th May 202012:07 pmRNSSecond Price Monitoring Extn
19th May 202012:02 pmRNSPrice Monitoring Extension
18th May 20204:41 pmRNSSecond Price Monitoring Extn
18th May 20204:36 pmRNSPrice Monitoring Extension
28th Apr 202011:17 amRNS2-DTech awarded grant
23rd Apr 20207:00 amRNSRolls-Royce chooses to partner with GEIC & 2-DTech
15th Apr 20205:10 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSClarification: Sharing Agreement & China JV
2nd Apr 20203:32 pmRNSHolding(s) in Company
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSHolding(s) in Company
27th Mar 20202:05 pmRNSSecond Price Monitoring Extn
27th Mar 20202:00 pmRNSPrice Monitoring Extension
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20202:05 pmRNSSecond Price Monitoring Extn
25th Mar 20202:00 pmRNSPrice Monitoring Extension
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSChina Update
23rd Mar 20203:06 pmRNSInvestor Communications
23rd Mar 20207:00 amRNSSubscription to raise £6 million
4th Mar 20204:40 pmRNSSecond Price Monitoring Extn
4th Mar 20204:35 pmRNSPrice Monitoring Extension
3rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20204:36 pmRNSPrice Monitoring Extension
28th Feb 20207:00 amRNSInvestor Communications
26th Feb 202011:05 amRNSSecond Price Monitoring Extn
26th Feb 202011:00 amRNSPrice Monitoring Extension
25th Feb 20201:48 pmRNSCorporate update
18th Feb 20204:15 pmRNSChange of Substantial Shareholding
17th Feb 20207:00 amRNSChange of Nominated Adviser and Broker
12th Feb 20204:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.